Skip to main content
. Author manuscript; available in PMC: 2022 Sep 6.
Published in final edited form as: Am J Ophthalmol. 2022 May 6;241:120–129. doi: 10.1016/j.ajo.2022.04.022

TABLE 3.

Difference in Vessel Density and Foveal Avascular Zone Parameters From Macular Scans After Timolol Use, After Latanoprostene Bunod Use, and Between Timolol and Latanoprostene Bunod Use

Timolol vs Baseline P Value LBN vs Baseline P Value LBN vs Timolol P Value

Vessel density (%) (95% CI)
Wi (wiVD) −0.03 (−0.58 to 0.53) .92 0.76 (0.20–1.33) .009a 0.70 (0.10–1.29) .02a
 Wi superior hemi −0.14 (−0.72 to 0.43) .63 0.80 (0.22–1.38) .007a 0.86 (0.25–1.47) .006a
 Wi inferior hemi 0.10 (−0.47 to 0.66) .74 0.72 (0.14–1.29) .02a 0.51 (−0.11 to 1.13) .11
 Para fovea 0.08 (−0.68 to 0.85) .83 0.86 (0.05–1.66) .04a 0.63 (−0.27 to 1.53) .17
 Para superior hemi 0.07 (−0.75 to 0.89) .86 1.17 (0.32–2.02) .007a 0.98 (0.02–1.93) .047a
 Para inferior hemi 0.10 (−0.71 to 0.91) .81 0.54 (−0.35 to 1.43) .24 0.28 (−0.70 to 1.26) .57
Quadrant parafoveal vessel density (%) (95% CI)
 Temporal −0.09 (−0.91 to 0.73) .83 0.81 (−0.03 to 1.64) .06 0.70 (−0.22 to 1.63) .14
 Superior −0.11 (−0.97 to 0.75) .80 1.04 (0.10–1.97) .03a 1.03 (0.02–2.05) .048a
 Nasal 0.22 (−0.73 to 1.16) .66 0.87 (−0.11 to 1.86) .08 0.56 (−0.58 to 1.70) .34
 Inferior 0.35 (−0.54 to 1.24) .45 0.71 (−0.25 to 1.67) .15 0.23 (−0.88 to 1.33) .69
Foveal avascular zone (mm2) (95% CI)
 Area 0.00 (−0.01 to 0.01) .73 −0.00 (−0.01 to 0.01) .90 −0.00 (−0.01 to 0.01) .48
 Perimeter −0.01 (−0.04 to 0.03) .69 −0.02 (−0.05 to 0.02) .41 −0.01 (−0.05 to 0.03) .53
 FD 300 area density 0.17 (−0.69 to 1.02) .77 0.26 (−0.60 to 1.11) .56 0.09 (−0.95 to 1.13) .87

CI = confidence interval; LBN = latanoprostene bunod; wi = whole image; FD 300 area density = density in the area within 300 μm from the foveal avascular zone boundary; VD =vessel density.

a

Statistically significant (P < .05).